CHRISTOPHER MCCARLEY: Open Payments
NPI 1497768675 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 25 payments from 12 companies in 2025. Trend: 2023 $1,144 · 2024 $1,043 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $102 |
| AtriCure, Inc. | 3 | $74 |
| Artivion, Inc. | 2 | $73 |
| LeMaitre Vascular, Inc. | 3 | $61 |
| Abbott Laboratories | 2 | $50 |
| Edwards Lifesciences Corporation | 2 | $48 |
| ABIOMED | 2 | $45 |
| Dilon Technologies, Inc. | 2 | $45 |
| Kerecis Limited | 2 | $40 |
| Boston Scientific Corporation | 1 | $37 |
Products named: COREVALVE EVOLUT R, AMDS-Ascyrus Medical, NAVITOR, SYNERGY ABLATION SYSTEM, KONECT RESILIA, HEMOBLAST BELLOWS, Kerecis SurgiClose, XENOSURE BIOLOGIC PATCH.
Industry payments across MS — which companies pay providers there.
